Currently Enrolling
Trial Physician / Study Coordinator
Pam Lackner
Email Phone (216) 636-9628Site Name
Cleveland Clinic
9500 Euclid Avenue, Cleveland, OH 44195-0001
Find other locations for this trial:
Currently Enrolling
Eligibility Criteria
About the Drug
What is involved for the patient
Target Enrollment
Up to 125 patients FSGS / TR-MCD or DN are planned to be enrolled into the study.
Estimated End Date
TBC